Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations
This study suggests quinacrine may have repurposing potential for a large subset of mesothelioma patients.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Alimta | Asbestosis | Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Genetics | Mesothelioma | Study